BerandaSCNI • NASDAQ
add
Scinai Immunotherapeutics Ltd - ADR
Tutup sebelumnya
$0,85
Rentang hari
$0,81 - $0,86
Rentang tahun
$0,63 - $6,18
Kapitalisasi pasar
2,79Â jt USD
Volume Rata-Rata
44,74Â rb
Rasio P/E
0,10
Hasil dividen
-
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 386,50Â rb | 36,09% |
Biaya operasional | 1,25Â jt | -33,09% |
Penghasilan bersih | -2,07Â jt | 10,98% |
Margin laba bersih | -534,80 | 34,59% |
Penghasilan per saham | — | — |
EBITDA | -1,53Â jt | 0,10% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 989,00Â rb | -67,85% |
Total aset | 11,84Â jt | -20,27% |
Total liabilitas | 3,98Â jt | -82,01% |
Total ekuitas | 7,86 jt | — |
Saham yang beredar | 1,51 jt | — |
Harga terhadap nilai buku | 0,58 | — |
Tingkat pengembalian aset | -39,73% | — |
Tingkat pengembalian modal | -46,05% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -2,07Â jt | 10,98% |
Kas dari operasi | -1,29Â jt | 26,76% |
Kas dari investasi | -6,00Â rb | 0,00% |
Kas dari pembiayaan | 790,50Â rb | 6.487,50% |
Perubahan kas bersih | -482,00Â rb | 72,49% |
Arus kas bebas | -810,88Â rb | 32,55% |
Tentang
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
Didirikan
1 Jan 2003
Situs
Karyawan
31
